Drospirenone mixture with Ethinylestradiol
This product is a combined oral contraceptive formulation for research use, containing 3 mg of the progestin drospirenone and 0.030 mg (30 mcg) of the estrogen ethinyl estradiol. It is utilized in pharmacological studies to investigate hormone receptor interactions, metabolic effects, and the mechanisms of action of synthetic steroids in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
164017-31-6
Field of Research
Pharmacology & Drug Discovery
Smiles
C[C@@]12[C@] ([C@]3 ([C@] (CC1) (C=4C (CC3) =CC (O) =CC4) [H]) [H]) (CC[C@]2 (C#C) O) [H].C[C@@]12[C@]3 ([C@@]4 ([C@] ([C@]1 ([C@]5 ([C@] (CC2) ([C@]6 (C) C ([C@]7 ([C@@]5 (C7) [H]) [H]) =CC (=O) CC6) [H]) [H]) [H]) (C4) [H]) [H]) OC (=O) CC3
Molecular Formula
C44H54O5
Molecular Weight
662.90
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1101313-01 250 mg
α, α-Dimethyl-3- (2-propen-1-yl) benzenemethanol
Sign In for Pricing
View Details OR1101313-02 500 mg
α, α-Dimethyl-3- (2-propen-1-yl) benzenemethanol
Sign In for Pricing
View Details 
MBS7172229 Inquire
Rabbit anti-Escherichia coli O157:H7 (strain EC4115/EHEC) PNP Polyclonal Antibody
Sign In for Pricing
View Details